ArticlePDF Available

Symptom severity of patients with advanced cancer in palliative care unit: Longitudinal assessments of symptoms improvement

Authors:

Abstract and Figures

This study assessed the symptom severity of patients with advanced cancer in a palliative care unit and explored the factors associated with symptom improvement. This study was conducted in a palliative care unit in Taiwan between October 2004 and December 2009. Symptom intensity was measured by the “Symptom Reporting Form”, and graded on a scale of 0 to 4 (0 = none, and 4 = extreme). These measures were assessed on the 1 st , 3 rd , 5 th , and 7 th Day in the palliative care unit. The study data comprised routine clinical records and patients’ demographic data. Generalized estimating equation (GEE) was used to assess the symptom improvement, and investigate the factors associated with the symptom reporting form scores. Among the 824 recruited patients with advanced cancer, pain (78.4 %), anorexia (64.4 %) and constipation (63.5 %)were the most common and severe symptom. After controlling for other factors in the multivariate GEE model, the day of palliative care administration was a significant factor associated with all of the scales, except Days 7 on the dyspnoea and oedema scales and Day 5 on the anxiety scale. In addition, patients aged ≥ 65 years exhibited significantly lower scores on the pain, sleep disturbance, depression, and anxiety scales than did those aged < 65 years. Moreover, female patients exhibited higher scores on the vomiting, anorexia, oedema, depression, and anxiety scales than did male patients. Furthermore, patients with gastrointestinal tract cancer exhibited higher scores on the constipation, vomiting, anorexia, oedema, depression, and anxiety scales and lower scores on the dyspnoea scale than did those with lung cancer. Patients with breast cancer exhibited higher scores on the oedema scale and lower scores on the anxiety scale. Patients with genitourinary cancer exhibited higher scores on the vomiting and oedema scales and lower scores on the dyspnoea scale. Patients with head, neck, and oral cancer exhibited lower scores on the oedema scale alone. The symptom severity declined during the first week in the palliative care unit. In addition, differences in sex and primary cancer sites may contribute to varying degrees of symptom improvement.
Content may be subject to copyright.
R E S E A R C H A R T I C L E Open Access
Symptom severity of patients with
advanced cancer in palliative care unit:
longitudinal assessments of symptoms
improvement
Shu-Yu Tai
1,2,3,4
, Chung-Yin Lee
3
, Chien-Yi Wu
3
, Hui-Ya Hsieh
5
, Joh-Jong Huang
3
, Chia-Tsuan Huang
3*
and Chen-Yu Chien
6,7,8*
Abstract
Background: This study assessed the symptom severity of patients with advanced cancer in a palliative care unit
and explored the factors associated with symptom improvement.
Methods: This study was conducted in a palliative care unit in Taiwan between October 2004 and December 2009.
Symptom intensity was measured by the Symptom Reporting Form, and graded on a scale of 0 to 4 (0 = none,
and 4 = extreme). These measures were assessed on the 1
st
,3
rd
,5
th
, and 7
th
Day in the palliative care unit. The study
data comprised routine clinical records and patientsdemographic data. Generalized estimating equation (GEE)
was used to assess the symptom improvement, and investigate the factors associated with the symptom
reporting form scores.
Results: Among the 824 recruited patients with advanced cancer, pain (78.4 %), anorexia (64.4 %) and constipation
(63.5 %)were the most common and severe symptom. After controlling for other factors in the multivariate GEE model,
the day of palliative care administration was a significant factor associated with all of the scales, except Days 7 on the
dyspnoea and oedema scales and Day 5 on the anxiety scale. In addition, patients aged 65 years exhibited
significantly lower scores on the pain, sleep disturbance, depression, and anxiety scales than did those aged < 65 years.
Moreover, female patients exhibited higher scores on the vomiting, anorexia, oedema, depression, and anxiety scales
than did male patients. Furthermore, patients with gastrointestinal tract cancer exhibited higher scores on the
constipation, vomiting, anorexia, oedema, depression, and anxiety scales and lower scores on the dyspnoea scale
than did those with lung cancer. Patients with breast cancer exhibited higher scores on the oedema scale and
lower scores on the anxiety scale. Patients with genitourinary cancer exhibited higher scores on the vomiting and
oedema scales and lower scores on the dyspnoea scale. Patients with head, neck, and oral cancer exhibited lower
scores on the oedema scale alone.
Conclusion: The symptom severity declined during the first week in the palliative care unit. In addition, differences in
sex and primary cancer sites may contribute to varying degrees of symptom improvement.
Keywords: Advanced cancer, Palliative care, Symptom severity, Generalised estimating equation
* Correspondence: chtshu@kmu.edu.tw;chenyu@cc.kmu.edu.tw
Equal contributors
3
Department of Family Medicine, Kaohsiung Medical University Hospital,
Kaohsiung, Taiwan
6
Department of Otorhinolaryngology, School of Medicine, College of
Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan
Full list of author information is available at the end of the article
© 2016 Tai et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Tai et al. BMC Palliative Care (2016) 15:32
DOI 10.1186/s12904-016-0105-8
Content courtesy of Springer Nature, terms of use apply. Rights reserved.
Background
Cancer is a leading cause of death worldwide and
accounted for 8.2 million deaths in 2012 [1]. Since
1982, cancer has been the primary cause of death in
Taiwan and accounts for over 30,000 deaths each year
and this figure is increasing [2]. The Hospice Palliative
Care, which originated in England, aims to provide
symptom alleviation and holistic care through physical,
emotional, and spiritual approaches to terminally ill
patients towards the end of their lives. Until 2013, the
hospice care programmes available in Taiwan included
44 hospital-based inpatient hospice care wards (hospice
wards), 64 hospice home-care units (regular home visits
by nurses and other interdisciplinary staff), and 58 hos-
pitals with consultation or a combined care team [3].
Terminally ill patients with cancer suffer from several
physical and psychological symptoms and multiple organ
failures; therefore, one of their main needs is to be com-
fortable and symptom-free at the end stage of their lives
[4]. Consequently, the initial and essential component of
palliative cancer care is to provide advanced-cancer pa-
tients with symptom relief as soon as possible in lieu of
disease treatment [5, 6]. The previous studies may tell us
the symptom patterns [4, 710] and the good effect of
the intervention (ex.: the case management model, the
hospital- or day care- based palliative care teametc.)
in improving symptom control and even quality of life
[1114] among advanced cancer patients. However,
limited information is available regarding longitudinal
assessments of symptom improvement after admission
to a palliative care unit. Therefore, a clearer under-
standing of symptom improvement and factors associ-
ated with symptom improvement is required to provide
optimal symptom relief for patients with advanced can-
cer. Thus, the Symptom Reporting Form was used in
the present study to assess the symptom severity of pa-
tients with advanced cancer in a palliative care unit.
Methods
Study population
In this prospective study, participants were selected
from amongst consecutive patients with advanced can-
cer who consented and were admitted between October
2004 and December 2009 to the palliative care unit of
Kaohsiung Medical University Hospital, a medical centre
in Southern Taiwan. The inclusion criteria included age
older than 20 years, more than 1-week admission to the
palliative care unit, and adequate level of conscious-
ness to report symptoms in Mandarin or Taiwanese on
admission and in the consecutive symptom assess-
ments. The exclusion criteria included age younger
than 20 years, passing away within one week after ad-
mission to the palliative care unit, and inadequate level
of consciousness to report symptoms. The participants
were receiving care from a multidisciplinary team compris-
ing physicians, nurses, psychologists, social workers, clinical
Buddhist chaplains, and volunteers. The study protocol was
approved by the Kaohsiung Medical University Hospital
Institutional Review Board (KMUH-IRB-20140333). Since
all identifying personal information was not recorded, the
review board waived the requirement for written informed
consent from the patients involved.
Assessment instrument
The assessment tool was a symptom-reporting form
designed by experienced specialists, which assessed the
physical and psychosocial distress by using corresponding
scales (see Additional file 1). The physical and psycho-
social symptoms included pain, constipation, vomiting,
dyspnoea, loss of appetite, sleep disturbance, oedema, un-
comfortable, depression, and anxiety, graded on a scale of
0to4(0=none,1=mild,2=moderate,3=severe,and
4=extreme). The internal consistency of questionnaire,
Coefficients of Cronbachsαvalue for the baseline
measurement, was 0.715. Besides, 3 experts in the hos-
pice filed were invited to judge and modify the content
of the symptom reporting form and 7 experts to assess
the content validity. The average content validity index
(CVI) [15] was 0.91.
Symptom assessment and data collection
According to patient reports, the symptoms and their
severities were recorded by the physicians on Days 1, 3,
5, and 7 in the palliative care unit and reviewed by the
same staff members. Information regarding psychological
distress, including depression and anxiety, were collected
by medical staff and clinical psychologists. A consensus
regarding the psychological distress rating was obtained
after thorough discussion in team meetings which were
held once per week. The data for this study comprised
routine records, including patientsdemographic data
(age, sex, primary site of cancer, and length of time in
care) and the symptom reporting forms collected on Days
1, 3, 5, and 7 in the palliative care unit.
Training of the palliative care unit staff
According to the health insurance guidelines for pallia-
tive care, all the palliative team members, including phy-
sicians, nurses, psychologists, social workers, and clinical
Buddhist chaplains, were required to finish 80 h of pal-
liative care training which included basic, advanced, and
internship courses. In addition, all members were re-
quired to undergo 20 h of palliative training every year
to ensure the quality of care provided.
Statistical analysis
Descriptive statistical data were summarised as frequen-
cies and percentages for categorical variables, medians
Tai et al. BMC Palliative Care (2016) 15:32 Page 2 of 7
Content courtesy of Springer Nature, terms of use apply. Rights reserved.
and ranges for age and duration of palliative care re-
ceived, and means (standard deviations, SD) and median
(range) for symptom scores and other continuous vari-
ables. Patient age was categorised into 2 groups for eas-
ier comparisons (< 65 y and 65 y). To investigate the
factors associated with the symptom reporting form
scores, a generalised estimating equation (GEE) model
was applied to accommodate the correlated data of re-
peated measurements (on Days 1, 3, 5, and 7) in the
same patient. The symptom reporting score served as a
continuous dependent variable, whereas age, sex, and
type of cancer served as covariates. In addition, multi-
variate GEE models with identity links were used to cal-
culate the adjusted mean differences and standard
errors (SE) of the symptom scores and compare them
with those of an appropriate reference group. A 2-tailed
Pvalue of < .05 indicated statistical significance. All
statistical analyses were performed using the SAS soft-
ware (Version 9.2; SAS Institute Inc., Cary, NC, USA).
Results
The study participants were 824 hospitalised patients
with advanced cancer; 480 (58.3 %) of whom were men.
The median age was 61 years (range: 2197 y), and the
median duration in care was 20 days (7118 d). Regard-
ing the primary cancer type, gastrointestinal cancer was
the most common cancer type (32.4 %), followed by
head, neck, and oral cancer (22.4 %) and lung cancer
(18.2 %) (Table 1).
Pain (78.4 %) was the most common symptom, followed
by anorexia (64.4 %) and constipation (63.5 %). Regarding
symptom severity, pain (mean ± SD: 1.63 ± 1.23) was the
most severe symptom, followed by anorexia (1.24 ± 1.24),
constipation (0.92 ± 1.05), dyspnoea (0.82 ± 1.07), and
oedema (0.74 ± 1.10) (Table 2).
As mentioned previously, to investigate factors asso-
ciated with the symptom reporting scores, a GEE model
was applied to accommodate the correlated data of re-
peated measurements (on Days 1, 3, 5, and 7) in the
same patient. After controlling for other factors in the
multivariate GEE model, the day of palliative care ad-
ministration proved a significant factor associated with
all scales (all P0.05), except Day 7 on the dyspnoea
(P= .658) and oedema scales (P= .135) and Day 5 on
the anxiety scale (P= .452) (Tables 3 and 4). In addition,
after controlling for other factors in the multivariate
GEE model, patients aged 65 years exhibited significantly
lower scores on the pain, sleep disturbance, depression,
and anxiety scales than did those aged < 65 years (all
P.001). Moreover, after controlling for other factors in
the multivariate GEE model, the female patients exhib-
ited significantly higher scores on the vomiting (esti-
mate [SD]: 0.32 [0.16] points), anorexia (0.23 [0.06]
points), oedema (0.15 [0.16] points), depression (0.35
[0.11] points), and anxiety (0.77 [0.28] points) scales
than did the male patients (all P.05) (Tables 3 and 4).
Patients with gastrointestinal tract cancer exhibited
higher scores on the constipation (0.21 [0.11] points),
vomiting (0.90 [0.16] points), anorexia (0.59 [0.09]
points), oedema (0.59 [0.16] points), depression (0.39
[0.15] points), and anxiety (0.35 [0.14] points) scales
and lower scores on the dyspnoea (0.36 [0.12] points)
scale than did those with lung cancer. Patients with
breast cancer exhibited higher scores on the oedema
(1.43 [0.64] points) scale and lower scores on the anx-
iety (0.61 [0.20] points) scale than did those with lung
cancer. Furthermore, patients with genitourinary can-
cer exhibited higher scores on the vomiting (0.79 [0.19]
points) and oedema (0.82 [0.21] points) scales and
lower scores on the dyspnoea (0.45 [0.15] points)
scale than did those with lung cancer. Patients with
head, neck, and oral cancer exhibited lower scores on
the oedema (1.02 [0.23] points) scale alone than did
Table 1 Thebaselinedemographiccharacteristicsofall
participants
Total (N= 824)
N%
Age, year
Median (Range) 61 (2197)
< 65 461 56.0.
65 344 41.7
missing 19 2.3
Gender
Female 344 41.7
Male 480 58.3
Primary diagnosis
Lung cancer 150 18.2
Gastrointestinal cancer
a
267 32.4
Breast cancer 55 6.7
Genitourinary cancer
b
108 13.1
Head, neck, and oral cancer 185 22.4
Other cancers
c
59 7.2
Length of time in care
Median (Range) 20 (7118)
14 days 231 28.0
1530 days 361 43.8
3160 days 180 21.8
> 60 days 36 4.4
Missing 16
a
Cancers of the gastrointestinal tract from esophagus to the rectum, pancreas,
liver and gallbladder were combined to form this category
b
Cancers of the male and female genitals and the urinary tract were combined
to form this category
c
Cancers that were not included above
Tai et al. BMC Palliative Care (2016) 15:32 Page 3 of 7
Content courtesy of Springer Nature, terms of use apply. Rights reserved.
those with lung cancer. In addition, patients with other
cancers exhibited higher scores on the anorexia (0.48
[0.13] points), sleep disturbance (0.58 [0.21] points),
oedema (3.89 [0.54] points), uncomfortable (139.87
[0.19] points), and anxiety (3.08 [0.20] points) scales
than did those with lung cancer (Tables 3 and 4).
Discussion
This study demonstrated that the most severe symptoms of
patients hospitalised for palliative care are pain, anorexia
and constipation. In addition, the integration of hos-
pital palliative care demonstrated favourable improve-
ment in symptom severity. Moreover, differences in sex
and primary cancer sites may contribute to varying
degrees of improvement in symptom severity.
Terminally ill patients with cancer suffer from several
physical and psychological symptoms and multiple
organ failures; therefore, one of their main needs is to
be comfortable and symptom-free at the end stage of
their lives [16]. Thus, palliative cancer care essentially
Table 2 Change in severity of symptoms among 1
st
,3
rd
,5
th
,and 7
th
day after admission (N= 824)
Variable of symptom With
symptom
a
1
st
3
rd
5
th
7
th
Range of severity
(04)
N% Mean (SD) Median (range) Mean (SD) Median (range) Mean (SD) Median (range) Mean (SD) Median (range)
Pain 646 78.4 1.63 (1.23) 2 (04) 1.05 (0.99) 1 (04) 0.84 (0.90) 1 (04) 0.61 (0.81) 0 (04)
Constipation 463 63.5 0.92 (1.05) 1 (04) 0.81 (0.96) 1 (04) 0.75 (0.93) 1 (04) 0.72 (0.95) 0 (04)
Vomiting 313 38.0 0.62 (0.98) 0 (04) 0.43 (0.77) 0 (04) 0.34 (0.71) 0 (04) 0.26 (0.64) 0 (04)
Dyspnea 394 47.8 0.82 (1.07) 0 (04) 0.64 (0.92) 0 (04) 0.62 (0.90) 0 (04) 0.78 (1.12) 0 (04)
Anorexia 531 64.4 1.24 (1.24) 1 (04) 1.04 (1.14) 1 (04) 1.00 (1.14) 1 (04) 1.03 (1.28) 1 (04)
Sleep disturbance 356 43.2 0.67 (0.95) 0 (04) 0.50 (0.81) 0 (04) 0.46 (0.78) 0 (04) 0.35 (0.71) 0 (04)
Edema 340 41.3 0.74 (1.10) 0 (04) 0.67 (1.01) 0 (04) 0.66 (1.02) 0 (04) 0.71 (1.08) 0 (04)
Uncomfortable 364 44.2 0.67 (1.15) 0 (04) 0.60 (1.02) 0 (04) 0.57 (0.98) 0 (04) 0.55 (1.01) 0 (04)
Depression 333 40.4 0.58 (0.87) 0 (04) 0.47 (0.77) 0 (04) 0.43 (0.71) 0 (04) 0.31 (0.60) 0 (04)
Anxiety 280 34.0 0.45 (0.76) 0 (04) 0.38 (0.68) 0 (04) 0.36 (0.62) 0 (04) 0.25 (0.53) 0 (04)
a
The score at the 1
st
day of admission in this scale was equal to or more than 1
Table 3 Estimates from GEE
b
modles of indicators of pain, constipation, vomiting, dyspnea, and anorexia
Pain Constipation Vomiting Dyspnea Anorexia
Nβ(SE)
a
P-value β(SE)
a
P-value β(SE)
a
P-value β(SE)
a
P-value β(SE)
a
P-value
Age, year
< 65 Reference - Reference - Reference - Reference - Reference -
65 0.23 (0.06) < 0.001 0.19 (0.08) 0.087 0.06 (0.12) 0.614 0.07 (0.09) 0.428 0.04 (0.06) 0.475
Gender
Male 480 Reference - Reference - Reference - Reference - Reference -
Female 344 0.01 (0.06) 0.828 0.18 (0.12) 0.129 0.32 (0.16) 0.046 0.06 (0.09) 0.548 0.23 (0.06) < 0.001
Cancer
Lung cancer 150 Reference - Reference - Reference - Reference - Reference -
Gastrointestinal cancer 267 0.12 (0.08) 0.146 0.21(0.11) 0.044 0.90 (0.16) < 0.001 0.36 (0.12) 0.002 0.59 (0.09) < 0.001
Breast cancer 55 0.02 (0.13) 0.875 0.20 (0.19) 0.287 0.41 (0.23) 0.075 0.12 (0.18) 0.507 0.07 (0.15) 0.638
Genitourinary cancer 108 0.03 (0.10) 0.777 0.10 (0.14) 0.469 0.79 (0.19) <0.001 0.45 (0.15) 0.002 0.19 (0.12) 0.102
Head, neck, and oral cancer 185 0.15 (0.09) 0.108 0.10(0.13) 0.452 0.25 (0.22) 0.245 0.22 (0.13) 0.089 0.15 (0.13) 0.242
Other cancers 59 0.02 (0.12) 0.836 0.09 (0.21) 0.684 0.10 (0.34) 0.773 0.22(0.15) 0.140 0.48 (0.13) < 0.001
Day of palliative care
1
st
day 822 Reference - Reference - Reference - Reference - Reference -
3
rd
day 824 0.45 (0.02) < 0.001 0.20 (0.08) 0.013 0.35 (0.05) < 0.001 0.22 (0.03) < 0.001 0.18 (0.02) < 0.001
5
th
day 823 0.67 (0.03) < 0.001 0.22 (0.04) < 0.001 0.47 (0.08) < 0.001 0.25 (0.04) < 0.001 0.23 (0.03) < 0.001
7
th
day 822 0.98 (0.04) < 0.001 0.21 (0.06) < 0.001 1.04 (0.09) < 0.001 0.02 (0.05) 0.658 0.18 (0.04) < 0.001
a
Adjusted mean difference compared to referent group.
b
GEE:generalized estimating equation
Tai et al. BMC Palliative Care (2016) 15:32 Page 4 of 7
Content courtesy of Springer Nature, terms of use apply. Rights reserved.
aims to provide such patients with symptom relief and
higher quality of life [5, 17]. The findings of the present
study confirmed the efficacy of palliative care based on
the symptom improvement observed during the first
week of the palliative unit inpatient care, except on Day
7 of dyspnoea and oedema assessment and Day 5 of
anxiety assessment. Most previous studies have fo-
cused on the symptoms or symptom cluster screening
in patients with advanced cancer receiving palliative
care [7, 9, 18, 19]. Certain studies have conducted a
longitudinal follow-up to observe the quality of life,
symptom severity, and mood amongst outpatients with
advanced cancer [14, 18]. The present study recruited
824 participants who were all admitted to the palliative
care unit of a medical centre.
In addition, previous studies have focused on the roles
of age and sex differences in symptoms improvement
amongst patients with advanced cancer [9, 2023]. Con-
sistent with the findings of a previous systematic review
of symptom prevalence [9], we observed a significant as-
sociation between pain improvement and older age.
Moreover, similar associations were observed with sleep
disturbance, depression, and anxiety. These findings sug-
gest that younger patients require particular attention
and active monitoring during symptom management. In
addition considerable sex differences were observed re-
garding certain symptoms: female patients reported less
improvement of vomiting, anorexia, sleep disturbance,
depression, and anxiety after adjustment for age, primary
cancer site, and day of palliative care administration.
These results are consistent with those of a large-scale
study of patients who did not receive anticancer treat-
ments, which revealed marked sex differences in the
prevalence of nausea [9, 23] but is inconsistent with the
results of another similar study [18]. These differences
may be attributable to the different measurement
methods (symptom severity vs frequency), the different
treatment settings (in outpatients vs in a palliative unit
care), and varying analysis methods (adjustment of other
factors or repeated measurements). Therefore, additional
pooled data is required from such settings to determine
the effects of age and sex on symptom improvement in
such a patient population.
Moreover, our results helped identify the crucial as-
pects of symptom improvement for different primary
cancer sites. Regarding pain, no significant differences
were observed between the different types of cancer dur-
ing the first week of admission. Gastrointestinal symp-
toms, including constipation, vomiting, and anorexia,
were the most common and severe problems in patients
with advanced cancer, particularly those with advanced
gastrointestinal cancer; these symptoms may be attribut-
able to refractory ascites or intra-abdominal masses or
may be the side effects of opioid drugs administered to
Table 4 Estimates from GEE
b
modles of indicators of sleep disturbance, edema, uncomfortable, depression and anxiety
Sleep disturbance Edema Uncomfortable Depression Anxiety
Nβ(SE)
a
P-value β(SE)
a
P-value β(SE)
a
P-value β(SE)
a
P-value β(SE)
a
P-value
Age, year
< 65 Reference - Reference - Reference - Reference - Reference -
65 0.39 (0.11) < 0.001 0.26 (0.15) 0.093 0.08(0.11) 0.510 0.52 (0.10) < 0.001 0.80 (0.12) < 0.001
Gender
Male 480 Reference - Reference - Reference - Reference - Reference -
Female 344 (0.07) 0.664 0.15 (0.16) 0.046 0.06 (0.09) 0.548 0.35 (0.11) < 0.001 0.77 (0.28) 0.005
Cancer
Lung cancer 150 Reference - Reference - Reference - Reference - Reference -
Gastrointestinal cancer 267 0.37 (0.14) 0.008 0.59 (0.16) < 0.001 0.24 (0.16) 0.126 0.39 (0.15) 0.010 0.35(0.14) 0.012
Breast cancer 55 0.36 (0.37) 0.337 1.43 (0.64) 0.026 0.19 (0.28) 0.502 0.13 (0.20) 0.527 0.61 (0.20) 0.002
Genitourinary cancer 108 0.12 (0.19) 0.518 0.82 (0.21) < 0.001 0.16 (0.20) 0.419 0.22 (0.19) 0.252 0.04(0.17) 0.836
Head, neck, and oral cancer 185 0.03 (0.20) 0.881 1.02 (0.23) < 0.001 0.07 (0.19) 0.695 0.20(0.16) 0.215 0.34 (0.21) 0.105
Other cancers 59 0.58 (0.21) 0.006 3.89 (0.54) < 0.001 139.87(0.19) <0.001 0.26 (0.19) 0.166 3.08 (0.20) <0.001
Day of palliative care
1 822 Reference - Reference - Reference - Reference - Reference -
3 824 0.30 (0.04) < 0.001 0.11 (0.02) < 0.001 0.12 (0.04) 0.003 0.20 (0.03) < 0.001 0.10 (0.02) < 0.001
5 823 0.41(0.05) < 0.001 0.10 (0.02) < 0.001 0.17 (0.05) < 0.001 0.28 (0.04) < 0.001 0.02 (0.03) 0.452
7 822 0.66 (0.07) < 0.001 0.10 (0.07) 0.135 0.20 (0.06) 0.001 0.63 (0.06) < 0.001 1.24 (0.05) < 0.001
a
Adjusted mean difference compared to referent group.
b
GEE generalized estimating equation
Tai et al. BMC Palliative Care (2016) 15:32 Page 5 of 7
Content courtesy of Springer Nature, terms of use apply. Rights reserved.
such patients. Dyspnoea is a concerning symptom and is
more challenging to relieve in patients with advanced
lung cancer. It may result from the destruction of lung
tissue because of the growth and spreading of cancer
cells. In addition, improvement of sleep disturbance
was significantly lower amongst patients with advanced
gastrointestinal cancer than amongst those with ad-
vanced lung cancer. Compared with patients with ad-
vanced lung cancer, management of lymphoedema was
more challenging amongst those with advanced gastro-
intestinal, breast, and genitourinary cancer but easier
amongst those with head, neck, and oral cancer. How-
ever, the varying sites of lymphoedema amongst pa-
tients with different types of cancer required further
investigation to facilitate efficient management. Im-
provement of mood states, including depression and
anxiety, was more challenging amongst patients with
advanced gastrointestinal cancer than amongst those with
advanced lung cancer ones. Patients with advanced breast
cancer exhibited greater control of anxiety than did those
with lung cancer; the reasons for this difference may be
complicated because of other underlying physical symp-
toms (eg, dyspnoea).
The conditions of patients with advanced cancer may
rapidly deteriorate during their terminal phase, and
symptoms often worsen rapidly, suddenly, and unexpect-
edly. Thus, rapid and effective management of these
symptoms is essential to ensure adequate improvement
and a high quality of death. Therefore, the symptom se-
verity assessment of patients with advanced cancer in
palliative care units may provide additional valuable in-
formation regarding this crucial aspect of quality of care.
This was an observational study which evaluated clin-
ical experiences and thus had considerable limitations.
First, the symptom assessment checklist was a relatively
short instrument which assessed only 10 symptoms. Sec-
ond, assessment of the symptom scale scores every 2 days
may be too close. However, this study aimed to explore
the levels of symptom improvement after admission to
the palliative care unit, where the palliative care team
could resolve the symptoms as soon as possible. In
addition, because the cancer progression in such patients
may alter unexpectedly, we used a simple instrument to
closely assess the improvement in symptom severity.
Third, there was no information of the individual co-
morbidity, which may be associated with distressing
symptoms among advanced cancer patients. Fourth, this
study recruited only advanced cancer patients with ad-
equate level of consciousness to report symptoms and
was conducted in one palliative care unit of a medical
center, which may limit the generalization for all ter-
minal patients and all palliative care units. A consistent
symptom assessment tool for the routine quality indica-
tors of the palliative care units is needed in the future.
Conclusion
This study confirmed considerable symptom improve-
ment during the first week of palliative unit inpatient
care, except on Day 7 of dyspnoea and oedema assess-
ment and Day 5 of anxiety assessment. Improvement of
pain, sleep disturbance, depression, and anxiety were sig-
nificantly associated with older age. In addition, female
patients with advanced cancer reported lower symptom
improvement of vomiting, anorexia, sleep disturbance,
depression, and anxiety than did the corresponding male
patients. In addition, patients with different types of ad-
vanced cancer exhibited varying degrees of symptom
improvement.
Additional file
Additional file 1: The Symptom Reporting Form. (DOC 30 kb)
Abbreviations
GEE model: a generalised estimating equation model; Estimate [SD]: estimate
[standard deviation].
Competing interests
The authors declare that they have no competing interests.
Authorscontributions
CTH and CYC conceived of the study. SYT, CYL, CYW and HYH participated in
the data collection and coordination. Data analysis was mainly done by SYT
and CYC. SYT wrote the first draft. All authors (CTH, CYL, HYH, CYW, JJH and
CYC) contributed to the literature search and interpretation of the data. All
authors read and approved the final manuscript.
Acknowledgments
We appreciate the participation of all the advanced cancer patients in this
palliative care unit during the study period and the cooperation of the staff.
Besides, this study was supported by Kaohsiung Medical University Hospital
(KMUH101-1R44 and KMUH103-3R68), Kaohsiung Municipal Hsiao-Kang Hospital
(Kmhk-103-032) and the Ministry of Science and Technology (MOST103-2314-B-
037-004-MY3). None of which had any role in study design, data collection and
analysis, decision to publish, or preparation of the manuscript.
Author details
1
Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical
University, Kaohsiung, Taiwan.
2
Department of Family Medicine, School of
Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung,
Taiwan.
3
Department of Family Medicine, Kaohsiung Medical University
Hospital, Kaohsiung, Taiwan.
4
Department of Family Medicine, Kaohsiung
Municipal Ta-Tung Hospital, Kaohsiung Medical University, Kaohsiung,
Taiwan.
5
Department of Nursing, Kaohsiung Medical University Hospital,
Kaohsiung Medical University, Kaohsiung, Taiwan.
6
Department of
Otorhinolaryngology, School of Medicine, College of Medicine, Kaohsiung
Medical University, Kaohsiung, Taiwan.
7
Departments of Otorhinolaryngology,
Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.
8
Department of
Otolaryngology, Kaohsiung Municipal Hsiao-Kang Hospital, Kaohsiung
Medical University, Kaohsiung, Taiwan.
Received: 28 April 2015 Accepted: 7 March 2016
References
1. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer
statistics, 2012. CA: A Cancer Journal for Clinicians 2015;65:87-108.
2. Ministry of Health and Welfare. 2014; http://www.mohw.gov.tw/EN/Ministry/
Statistic.aspx?f_list_no=474&fod_list_no=3443.
Tai et al. BMC Palliative Care (2016) 15:32 Page 6 of 7
Content courtesy of Springer Nature, terms of use apply. Rights reserved.
3. Hospice Foundation of Taiwan. 2014; http://www.hospice.org.tw/2009/
english/index.php.
4. Solano JP, Gomes B, Higginson IJ. A comparison of symptom prevalence in
far advanced cancer, AIDS,heart disease, chronic obstructive pulmonary
disease and renal disease. J Pain Symptom Manage 2006;31:58-69.
5. Grunberg S. New directions in supportive care. Support Care Cancer. 2005;
13:1357.
6. Hoekstra J, de Vos R, van Duijn NP, Schade E, Bindels PJ. Using the
symptom monitor in a randomized controlled trial: the effect on symptom
prevalence and severity. J Pain Symptom Manage 2006;31:22-30.
7. Tsai JS, Wu CH, Chiu TY, Hu WY, Chen CY. Symptom patterns of advanced
cancer patients in a palliative care unit. Palliat Med. 2006;20:61722.
8. Murtagh FEM, Addington-Hall J, Higginson IJ. The prevalence of symptoms
in end-stage renal disease: a systematic review. Adv Chronic Kidney Dis.
2007;14:8299.
9. Teunissen SC, Wesker W, Kruitwagen C, de Haes HC, Voest EE, de Graeff A.
Symptom prevalence in patients with incurable cancer: a systematic review.
J Pain Symptom Manage. 2007;34:94104.
10. Dhingra L, Lam K, Homel P, Chen J, Chang VT, Zhou J, Chan S, Lam WL,
Portenoy R. Pain in underserved community-dwelling Chinese American
cancer patients: demographic and medical correlates. Oncologist. 2011;16:
52333.
11. Ozcelik H, Fadiloglu C, Karabulut B, Uyar M. Examining the effect of the case
management model on patient results in the palliative care of patients with
cancer. Am J Hosp Palliat Med. 2013.
12. Kao C-Y, Hu W-Y, Chiu T-Y, Chen C-Y. Effects of the hospital-based palliative care
team on the care for cancer patients: an evaluation study. Int J Nurs Stud. 2013.
13. Goodwin DM, Higginson IJ, Myers K, Douglas HR, Normand CE. Effectiveness
of palliative day care in improving pain, symptom control, and quality of
life. J Pain Symptom Manage. 2003;25:20212.
14. Bakitas M, Lyons K, Hegel MT, et al. Effects of a palliative care intervention
on clinical outcomes in patients with advanced cancer: the project enable ii
randomized controlled trial. JAMA. 2009;302:7419.
15. LYNN MR. Determination and quantification of content validity. Nurs Res.
1986;35:3826.
16. Klinkenberg M, Willems DL, van der Wal G, Deeg DJ. Symptom burden in
the last week of life. J Pain Symptom Manage. 2004;27:513.
17. Hoekstra J, Bindels PJ, van Duijn NP, Schade E. The symptom monitor. A diary
for monitoring physical symptoms for cancer patients in palliative care:
feasibility, reliability and compliance. J Pain Symptom Manage. 2004;27:2435.
18. Yamagishi A, Morita T, Miyashita M, Kimura F. Symptom prevalence and
longitudinal follow-up in cancer outpatients receiving chemotherapy. J Pain
Symptom Manage. 2009;37:82330.
19. Tsai JS, Wu CH, Chiu TY, Chen CY. Significance of symptom clustering in palliative
care of advanced cancer patients. J Pain Symptom Manage. 2010;39:65562.
20. Grond S, Zech D, Diefenbach C, Bischoff A. Prevalence and pattern of symptoms
in patients with cancer pain: a prospective evaluation of 1635 cancer patients
referred to a pain clinic. J Pain Symptom Manage. 1994;9:37282.
21. Lidstone V, Butters E, Seed PT, Sinnott C, Beynon T, Richards M. Symptoms
and concerns amongst cancer outpatients: identifying the need for
specialist palliative care. Palliat Med. 2003;17:58895.
22. Lo RS, Ding A, Chung TK, Woo J. Prospective study of symptom control in 133
cases of palliative care inpatients in Shatin Hospital. Palliat Med. 1999;13:33540.
23. Walsh D, Donnelly S, Rybicki L. The symptoms of advanced cancer:
relationship to age, gender, and performance status in 1,000 patients.
Support Care Cancer. 2000;8:1759.
We accept pre-submission inquiries
Our selector tool helps you to find the most relevant journal
We provide round the clock customer support
Convenient online submission
Thorough peer review
Inclusion in PubMed and all major indexing services
Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central
and we will help you at every step:
Tai et al. BMC Palliative Care (2016) 15:32 Page 7 of 7
Content courtesy of Springer Nature, terms of use apply. Rights reserved.
1.
2.
3.
4.
5.
6.
Terms and Conditions
Springer Nature journal content, brought to you courtesy of Springer Nature Customer Service Center GmbH (“Springer Nature”).
Springer Nature supports a reasonable amount of sharing of research papers by authors, subscribers and authorised users (“Users”), for small-
scale personal, non-commercial use provided that all copyright, trade and service marks and other proprietary notices are maintained. By
accessing, sharing, receiving or otherwise using the Springer Nature journal content you agree to these terms of use (“Terms”). For these
purposes, Springer Nature considers academic use (by researchers and students) to be non-commercial.
These Terms are supplementary and will apply in addition to any applicable website terms and conditions, a relevant site licence or a personal
subscription. These Terms will prevail over any conflict or ambiguity with regards to the relevant terms, a site licence or a personal subscription
(to the extent of the conflict or ambiguity only). For Creative Commons-licensed articles, the terms of the Creative Commons license used will
apply.
We collect and use personal data to provide access to the Springer Nature journal content. We may also use these personal data internally within
ResearchGate and Springer Nature and as agreed share it, in an anonymised way, for purposes of tracking, analysis and reporting. We will not
otherwise disclose your personal data outside the ResearchGate or the Springer Nature group of companies unless we have your permission as
detailed in the Privacy Policy.
While Users may use the Springer Nature journal content for small scale, personal non-commercial use, it is important to note that Users may
not:
use such content for the purpose of providing other users with access on a regular or large scale basis or as a means to circumvent access
control;
use such content where to do so would be considered a criminal or statutory offence in any jurisdiction, or gives rise to civil liability, or is
otherwise unlawful;
falsely or misleadingly imply or suggest endorsement, approval , sponsorship, or association unless explicitly agreed to by Springer Nature in
writing;
use bots or other automated methods to access the content or redirect messages
override any security feature or exclusionary protocol; or
share the content in order to create substitute for Springer Nature products or services or a systematic database of Springer Nature journal
content.
In line with the restriction against commercial use, Springer Nature does not permit the creation of a product or service that creates revenue,
royalties, rent or income from our content or its inclusion as part of a paid for service or for other commercial gain. Springer Nature journal
content cannot be used for inter-library loans and librarians may not upload Springer Nature journal content on a large scale into their, or any
other, institutional repository.
These terms of use are reviewed regularly and may be amended at any time. Springer Nature is not obligated to publish any information or
content on this website and may remove it or features or functionality at our sole discretion, at any time with or without notice. Springer Nature
may revoke this licence to you at any time and remove access to any copies of the Springer Nature journal content which have been saved.
To the fullest extent permitted by law, Springer Nature makes no warranties, representations or guarantees to Users, either express or implied
with respect to the Springer nature journal content and all parties disclaim and waive any implied warranties or warranties imposed by law,
including merchantability or fitness for any particular purpose.
Please note that these rights do not automatically extend to content, data or other material published by Springer Nature that may be licensed
from third parties.
If you would like to use or distribute our Springer Nature journal content to a wider audience or on a regular basis or in any other manner not
expressly permitted by these Terms, please contact Springer Nature at
onlineservice@springernature.com
... Regarding symptoms' severity, the most severe symptoms observed in our cohort were lack of appetite, weight loss, lack of energy, pain, cough, and shortness of breath, while the most distressing symptoms were shortness of breath followed by pain. This came matched with a number of other studies, for instance, when comparing to the studies of Tai et al, [24] and that of Lis et al, [25], as the former recruited 824 patients with advanced cancer, and found pain (78.4 %), anorexia (64.4 %) and constipation (63.5 %) to be the most common and severe symptom, while the latter recruited 386 patients and the resulting symptoms were tiredness (32.8%), difficulty sleeping (23.8%), and lack of appetite (20.2%), whereas pain (28.9%) and tiredness (24.3%) were most bothersome. These results were also similar to those reported by Huijer et al, [26] who performed a cross-sectional study on 200 adult cancer patients from three oncology units at a major tertiary teaching hospital who found the most prevalent symptom to be lack of energy. ...
... Regarding symptoms' severity, the most severe symptoms observed in our cohort were lack of appetite, weight loss, lack of energy, pain, cough, and shortness of breath, while the most distressing symptoms were shortness of breath followed by pain. This came matched with a number of other studies, for instance, when comparing to the studies of Tai et al, [24] and that of Lis et al, [25], as the former recruited 824 patients with advanced cancer, and found pain (78.4 %), anorexia (64.4 %) and constipation (63.5 %) to be the most common and severe symptom, while the latter recruited 386 patients and the resulting symptoms were tiredness (32.8%), difficulty sleeping (23.8%), and lack of appetite (20.2%), whereas pain (28.9%) and tiredness (24.3%) were most bothersome. These results were also similar to those reported by Huijer et al, [26] who performed a cross-sectional study on 200 adult cancer patients from three oncology units at a major tertiary teaching hospital who found the most prevalent symptom to be lack of energy. ...
... Hospice palliative care is part of the solution to what ails the world's current health-care systems. Consistently, palliative care leads to effective symptom control (Shu-Yu et al. 2016), improved quality of life (Temel et al. 2010), less unnecessary hospitalization (Morrison et al. 2008), realization of dignity (Chochinov et al. 2011), and reduced cost both for patients and families as well as providers (Smith et al. 2014). ...
... Palliative care in China is still in its infancy (20,21). In the greater China region, models of palliative care that delivered specialist palliative care services in various settings were reported (21), including hospitals (22), inpatient hospice units (23,24), nursing home (25), and homebased care (26)(27)(28). Furthermore, few studies have focused on the collaborative experience of various specialists in early palliative care models, as well as the impact of China's unique population characteristics and different regional cultural customs on palliative care. ...
Article
Full-text available
Purpose More effective approaches are needed to improve the prognosis of non-small-cell lung cancer (NSCLC) patients. Thus, we used the E-warm model to assess how early integration of interdisciplinary palliative care was related to the quality of life (QoL), psychological functioning, pain management, and nutrition factors of NSCLC patients. Methods This randomized controlled trial enrolled 280 newly diagnosed NSCLC patients, which were randomly divided (1:1) into combined early palliative care (CEPC) and standard oncological care (SC) groups. At baseline and after 24 weeks, the Functional Assessment of Cancer Therapy-Lung (FACT-L) scale, Hospital Anxiety and Depression Scale (HADS), and the Patient Health Questionnaire-9 (PHQ-9) were used to assess QoL and psychological function, respectively. The Numerical Rating Scale (NRS) and Patient-Generated Subjective Global Assessment (PG-SGA) were used to assess cancer patients’ pain and nutrition levels. The primary outcome was overall survival (OS). Secondary outcomes comprised changes in the QoL, psychological functioning, pain, and nutrition state. The intention-to-treat method was applied for analysis. This study was registered at www.chictr.org.cn (ChiCTR2200062617). Results Of the 140 patients enrolled in the CEPC and SC groups, 102 and 82 completed the research. The CEPC group presented higher QoL than the SC group ( p < 0.05). Additionally, fewer patients presented depressive symptoms in the CEPC group than in the SC group ( p < 0.05), as well as better nutritional status ( p = 0.007) and pain management ( p = 0.003). Compared to the SC group, CEPC patients had significantly longer OS (20.4 vs . 24.6 months, p = 0.042; HR: 0.19; 95% CI: 0.04-0.85, p = 0.029). Conclusion With combined early palliative care, NSCLC patients lived longer, had better QoL, were psychologically stable, were in less pain, and were more nutritionally satisfied.
... A dynamic network of palliative care services can integrate this earlier approach for the adult patients [22]. Acute palliative care units in the hospital may take care for acutely ill, palliative care patients, to obtain clinical stabilization and making it possible to discharge them at home [38]. Ideally, hospice care too could focus on Table 2 Interventions which are typical of PPC that can implemented within APC service Intervention Aim ·Earlier referral to PC service ·Early detection of needs and planning of appropriate therapies ·Simultaneity with disease-specific treatment ·Reassuring the patient on continuity of care ·Better coping with cumbersome/painful but potentially curative treatments ·Better definition of prognosis in complicated cases ·Some specific treatments may retain a palliative role in late stages (e.g. ...
Article
Full-text available
Adult and pediatric palliative care (PC) share common aims and ethical principles but differ in many organizational and practical aspects. The aim of this narrative review is to analyze these differences and focus on which key aspects of pediatric palliative care could integrate adult services for a better care of suffering patients. Interventions which are peculiar of pediatric PC respect to adult PC include: an earlier referral to the PC service to identify the needs and plan the interventions at an earlier stage of the disease; consequently, a more systematic cooperation with the disease-specific physicians to reduce the burden of treatments; a better integration with the community and the social surroundings of the patients, to prevent social isolation and preserve their social role; a more dynamic organization of the PC services, to give patients the chance of being stabilized at in-hospital or residential settings and subsequently discharged and cared at home whenever possible and desired; the implementation of respite care for adults, to help the families coping with the burden of the disease of their beloved and promote the home-based PC. This review underlines the relevance of some key-aspects of pediatric PC that can be beneficial also within PC of adults. Its findings give the chance for a more dynamic and modern organization of adult PC services and may serve as a basis of future research for new interventions.
... [1][2][3] Little is known about how these symptoms evolve in the last days to hours of life. [4][5][6] Since 2001, the Care Programme for the Dying (CPD) is used in a number of healthcare organisations in the Netherlands. The CPD is started when the multidisciplinary care team expects the death of a patient to occur within hours to days and supports healthcare providers in systematically assessing goals of care in the physical, psychosocial and spiritual domains. ...
Article
Full-text available
Objective Provide insight in the prevalence of symptoms in patients who are in the last days of life. Methods A retrospective descriptive analysis of data on patients who died between 2012 and 2019 at the age of 18 or older in 1 of 20 Dutch healthcare facilities, including hospitals, inpatient hospices and long-term care facilities. We analysed data from 4 hourly registrations in the Care Programme for the Dying Person, to assess for how many patients symptom-related goals of care were not achieved. We looked at the first 4 hours episode after the start of the Care Programme and the last 4 hours episode prior to death. Results We analysed records of 2786 patients. In the first 4 hours episode, at least one symptom-related care goal was not achieved for 28.5%–42.8% of patients, depending on the care setting. In the last 4 hours episode, these percentages were 17.5%–26.9%. Care goals concerning pain and restlessness were most often not achieved: percentages varied from 7.3% to 20.9% for pain and from 9.3% to 21.9% for restlessness. Conclusions Symptom control at the end of life is not optimal in a substantial minority of patients. Systematic assessment and attention as well as further research on symptom management are of the essence.
Article
Background The palliative care (PC) needs of patients with head and neck cancer (HNC) are complex, due to high and unique symptom burdens. Uniform outcome measures are critical to assessing the impact of PC interventions in HNC. Methods A scoping review of outcome measures used in patients with HNC receiving PC was performed using PubMed, Embase, and Web of Science from 1980 to 2022. Results Of 20 eligible studies, 19 unique instruments were identified which assessed 22 physical, 5 mental, 4 social, 7 related quality of life, and 9 advanced care planning outcomes. Instruments were underutilized, with a larger number of outcomes measurable for instruments used than were reported. The average instrument assessed three domains whereas the average study only reported outcomes from two domains. Conclusions Comparison across studies is limited due to heterogeneity in outcome measures. Future work is needed to develop core PC outcome measures for use in HNC care.
Article
Full-text available
The aim of the current study is to evaluate the different degrees of hospice care in improving patients’ autonomy in decision-making and reducing aggressiveness of cancer care in terminal-stage cancer patients, especially in reducing polypharmacy and excessive life-sustaining treatments. This was a retrospective cross-sectional study conducted in a single medical center in Taiwan. Patients with advanced cancer who died in 2010–2019 were included and classified into three subgroups: hospice ward admission, hospice shared care, and no hospice care involvement. In total, 8719 patients were enrolled, and 2097 (24.05%) admitted to hospice ward; 2107 (24.17%) received hospice shared care, and 4515 (51.78%) had no hospice care. Those admitted to hospice ward had significantly higher rates of having completed do-not-resuscitate order (100%, p < 0.001) and signed the do-not-resuscitate order by themselves (48.83%, p < 0.001), and they had lower aggressiveness of cancer care (2.2, p < 0.001) within the 28 days before death. Hospice ward admission, hospice shared care, and age > 79 years were negatively associated with aggressiveness of cancer care. In conclusion, our study showed that patients with end-of-life hospice care related to higher patient autonomy in decision-making and less excessively aggressive cancer care; the influence of care was more overt in patients approaching death. Further clinical efforts should be made to clarify the patient and the families’ satisfaction and perceptions of quality after hospice care involvement.
Article
Purpose: To determine whether cannabidiol (CBD) oil can improve symptom distress in patients with advanced cancer receiving palliative care. Methods: Participants were adults with advanced cancer and symptom distress (Edmonton Symptom Assessment Scale [ESAS] total score of ≥ 10/90) who received titrated CBD oil 100 mg/mL, 0.5 mL once daily to 2 mL three times a day, or matched placebo for 28 days. The primary outcome was ESAS total symptom distress score (TSDS) at day 14. Response was defined as a decrease in TSDS by ≥ 6 at day 14. Secondary outcomes were ESAS TSDS over time, individual symptom scores, patient-determined effective dose, opioid use, Global Impression of Change, depression, anxiety, quality of life, and adverse events. Results: Of the 144 patients randomly assigned, the planned sample size of 58 participants on CBD and 63 on placebo reached the primary analysis point (day 14). The unadjusted change in TSDS from baseline to day 14 was -6.2 (standard deviation, 14.5) for placebo and -3.0 (standard deviation, 15.2) for CBD with no significant difference between arms (P = .24). Similarly, there was no detected difference in proportion of responders (placebo: 37 of 63 [58.7%], CBD: 26 of 58 [44.8%], P = .13). All components of ESAS improved (fell) over time with no difference between arms. The median dose of participant-selected CBD was 400 mg per day with no correlation with opioid dose. There was no detectable effect of CBD on quality of life, depression, or anxiety. Adverse events did not differ significantly between arms apart from dyspnea that was more common with CBD. Most participants reported feeling better or much better at days 14 (53% CBD and 65% placebo) and 28 (70% CBD and 64% placebo). Conclusion: CBD oil did not add value to the reduction in symptom distress provided by specialist palliative care alone.
Article
Full-text available
PurposeWe aimed to investigate the improvement in symptoms, quality of life, patient and family satisfaction with care, and direct costs resulting from a palliative care program based case management model.Methods The research was implemented at the Medical Oncology Clinic hospital of a University between September 2009 and September 2011. The research sample consisted of a total of 44 patients (22 control and 22 intervention group). The research tools were the Edmonton Symptom Diagnosis System, the Karnofsky Performance Scale, the EORTCQLQ-C30 Quality of Life Scale, a patient and family satisfaction form, and a patient cost record form.ResultsThe difference between total symptom mean scores and the sub-dimension symptoms of pain, fatigue, nausea, depression, anxiety, lack of appetite, lethargy, well-being, dyspnea, and constipation post-hospitalization and post-discharge of patients in the control and experimental groups were found to be statistically significant (p < 0.05). The level of decrease in symptom severity in the experimental group patients was more than in the control group (p < 0.000). The satisfaction level of patients and family in the palliative care based case management service was higher than that for conventional service in the control group (p < 0.05). No statistical difference was detected between the experimental and control groups regarding health costs and duration of hospitalization (p > 0.05).Conclusion We provided a better symptom control, improved the patient s quality of life (excluding physical and congnitive functions), and patient and family satisfaction levels were higher in the palliative care based case management intervention group, but direct health costs were not affected.
Article
Full-text available
Little is known about cancer pain in Chinese Americans. The objective of this study was to describe the epidemiology of pain in this population. This information is needed to identify and address unmet clinical needs for culturally relevant interventions targeting pain and its consequences. A consecutive sample of underserved ethnic Chinese patients in a large community-based oncology practice was screened for persistent or frequent pain. Those patients with pain completed translated instruments assessing demographics, linguistic acculturation, disease-related characteristics, and pain-related characteristics. Of 312 patients screened, 178 (57.1%) reported frequent or persistent pain, 175 were eligible, and 170 participated. Most participants (85.9%) were born in China and 84.7% overall spoke Cantonese only. The most common cancers were gastrointestinal (28.2%), lung (21.8%), breast (20.6%), head and neck (12.9%), and genitourinary (4.7%); 43.5% had metastatic disease. The mean worst pain severity on a 0-10 numeric scale was 4.7 (standard deviation, 2.4), with 28.2% of patients rating their worst pain at ≥7 of 10. Although 37.6% used opioids and 47.1% used nonopioids, 45.8% reported "little" or "no" pain relief from medications. Complementary or alternative medicine therapies for cancer pain were used by 35.8%. In multiple regression analyses, worst pain was positively associated with acculturation to the English language and opioid therapy, and pain-related distress was positively associated with opioid therapy. Pain is prevalent among community-dwelling, ethnic Chinese American cancer patients. Additional studies are needed to confirm these results and investigate the finding that higher linguistic acculturation is associated with reports of more intense pain.
Article
Cancer constitutes an enormous burden on society in more and less economically developed countries alike. The occurrence of cancer is increasing because of the growth and aging of the population, as well as an increasing prevalence of established risk factors such as smoking, overweight, physical inactivity, and changing reproductive patterns associated with urbanization and economic development. Based on GLOBOCAN estimates, about 14.1 million new cancer cases and 8.2 million deaths occurred in 2012 worldwide. Over the years, the burden has shifted to less developed countries, which currently account for about 57% of cases and 65% of cancer deaths worldwide. Lung cancer is the leading cause of cancer death among males in both more and less developed countries, and has surpassed breast cancer as the leading cause of cancer death among females in more developed countries; breast cancer remains the leading cause of cancer death among females in less developed countries. Other leading causes of cancer death in more developed countries include colorectal cancer among males and females and prostate cancer among males. In less developed countries, liver and stomach cancer among males and cervical cancer among females are also leading causes of cancer death. Although incidence rates for all cancers combined are nearly twice as high in more developed than in less developed countries in both males and females, mortality rates are only 8% to 15% higher in more developed countries. This disparity reflects regional differences in the mix of cancers, which is affected by risk factors and detection practices, and/or the availability of treatment. Risk factors associated with the leading causes of cancer death include tobacco use (lung, colorectal, stomach, and liver cancer), overweight/obesity and physical inactivity (breast and colorectal cancer), and infection (liver, stomach, and cervical cancer). A substantial portion of cancer cases and deaths could be prevented by broadly applying effective prevention measures, such as tobacco control, vaccination, and the use of early detection tests. CA Cancer J Clin 2015;65: 87-108. (c) 2015 American Cancer Society.
Article
Patients with advanced cancer often experience multiple concurrent symptoms. To explore this symptom clustering and its associated parameters, we prospectively surveyed 427 consecutive patients on admission to the Palliative Care Unit. There were 222 males (52.0%) and 205 females (48.0%), with a median age of 66 years (range: 27-93 years). The main tumor sites were lung (19.9%), liver (18.0%), and colorectum (11.0%). The median survival was 13 days (1-418 days). Symptoms were assessed using a face-valid Symptom Reporting Form. We identified five symptom clusters by exploratory factor analysis. Clusters were named "loss of energy," "poor intake," "autonomic dysfunction," "aerodigestive impairment," and "pain complex." We used nonhierarchical cluster analysis to divide the 394 patients with complete data into six groups. Each group was characterized by a particular pattern that was composed of different symptom clusters. Survival, functional performance, bone metastasis, and fluid accumulation were significantly associated with symptom clustering in six groups of patients. The severity of psychological distress also related to their physical deterioration. These data suggest that different underlying mechanisms associate with symptom clustering. Further elucidation of these processes may assist in symptom management.
Article
Palliative care for cancer patients receiving chemotherapy in the outpatient setting is important. The aims of this study were 1) to identify symptom prevalence and intensity in cancer patients receiving chemotherapy and 2) to describe longitudinal follow-up data obtained from repeated assessment using the distress thermometer (DT). Questionnaires were distributed to consecutive cancer outpatients newly starting chemotherapy at the first appointment and at every hospital visit. The questionnaire included the severity of 11 symptoms (M. D. Anderson Symptom Inventory [MDASI], Japanese version), the DT, and the need for help in four psychosocial areas (decision-making, economic problems, nutrition, and daily activities). In total, 4000 questionnaires were returned by 462 patients. The frequently identified problems were oral problems (21%), insomnia (19%), psychological distress (defined as a DT score of 6 or more; 15%), help with information and decision-making (14%), severe fatigue (8.2%), and severe appetite loss (6.3%). Cluster analysis identified four symptom clusters: 1) fatigue and somnolence; 2) pain, dyspnea, and numbness; 3) nausea, appetite loss, and constipation; and 4) psychological distress. Of 165 patients with a DT of score 6 or more, 115 patients (70%) demonstrated a DT score below 6 at a median of 17 days follow-up. In the remaining 50 patients who had a DT score of 6 or more at follow-up, 34 patients (68%) had one or more physical symptoms rated at 7 or more on an 11-point numeric rating scale. Compared with patients with a DT score below 6 at follow-up, patients with a DT score of 6 or more at follow-up had higher levels of all physical symptoms. Frequent symptoms experienced by cancer outpatients receiving chemotherapy may be categorized as: 1) psychosocial issues (insomnia, psychological distress, decision-making support); 2) nutrition-gastrointestinal issues (oral problems, appetite loss, nausea); 3) fatigue; and 4) pain, dyspnea, and numbness. Developing a systematic intervention program targeting these four areas is urgently required. The DT score may be highly influenced by coexisting physical symptoms, and future studies to develop an appropriate system to identify patients with psychiatric comorbidity are necessary.
Article
The arbitrary assertion of two of three experts does not establish content validity. Application of a two-stage process that incorporates rigorous instrument development practices and quantifies the aspects of content validity is required. In the first stage of this process, the content domain or dimensions are identified and items are generated to reflect the scope of the content domain of a cognitive variable or each of the dimensions of an affective variable. Once generated, the items are assembled in a usable, testable format. The instrument and domain or dimension specifications are then presented to a panel of experts, the size of which is an a priori decision, for their judgment of the items using a 4-point ordinal rating scale. Using the item evaluation, CVI calculations are applied to both the items and the entire instrument. The experts are asked, as a part of the content validity assessment, to identify areas of omission and to suggest areas of item improvement or modification. Admittedly, there are times when adherence to such rigor may not be feasible. When less stringent methods of determining validity are applied, it should not be said that content validity has been determined. Opponents of the process described in this article might argue that these applications and expectations exceed practical application and that this process is therefore too rigorous. Content validity, by its nature and definition, demands rigor in its assessment, and its assessment is, in fact, critical. Such a rigorous process for content validity determination is offered because content validity is an inexpendable form of validity which is rapidly losing credibility due to its less than standardized and rigorous assessments. Content validity, different from all other forms of validity, is crucial to the understanding of research findings and their practical or theoretical applications. It is worth the rigor.
Article
In a prospective study, the prevalence of 15 physical symptoms and symptom groups was evaluated in 1635 cancer patients referred to a pain clinic. In addition to pain, patients suffered an average of 3.3 symptoms: insomnia (59%), anorexia (48%), constipation (33%), sweating (28%), nausea (27%), dyspnea (24%), dysphagia (20%), neuropsychiatric symptoms (20%), vomiting (20%), urinary symptoms (14%), dyspepsia (11%), paresis (10%), diarrhea (6%), pruritus (6%), and dermatological symptoms (3%). While symptom prevalence was influenced by tumor site, pain intensity, and opioid treatment, only a minor relationship was seen between symptoms and gender, age, or tumor stage. The data emphasize that it is not sufficient to simply address pain during the treatment of patients with cancer pain; a more global approach to symptom management is necessary.